Update: TransCode Therapeutics Shares Slump After $10 Million Direct Offering of Stock, Warrants

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Update: TransCode Therapeutics Shares Slump After $10 Million Direct Offering of Stock, Warrants

, MT Newswires - 2:43 PM ET 3/24/2025 default

02:43 PM EDT, 03/24/2025 (MT Newswires) -- (Updates with stock price movement in the headline and the first paragraph.)

TransCode Therapeutics ( RNAZ ) shares slumped past 38% in recent Monday trading after the company said it was selling shares to raise $10 million.

TransCode on Sunday said it has agreed to sell about 10.3 million shares of its common stock and warrants to purchase up to 10.3 million shares at $0.98 per share and accompanying warrant for total expected gross proceeds of $10 million.

The warrants will be exercisable at $0.86 per share.

Net proceeds will be used for product development activities, working capital and other general corporate purposes, the company said.

Closing of the offering is expected to occur Tuesday, subject to customary closing conditions.

Price: 0.69, Change: -0.43, Percent Change: -38.48

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.